Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Amgen
Henry Ford Health System
Bristol-Myers Squibb
GU Research Network, LLC
Emory University
Hoffmann-La Roche
Royal Marsden NHS Foundation Trust
University of Toledo
Incyte Corporation
Incyte Corporation
University of Texas Southwestern Medical Center
Loyola University
Eli Lilly and Company
Virginia Commonwealth University
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Spectrum Pharmaceuticals, Inc
AstraZeneca